U.S. FDA flags Dabur's Dadra plant for data integrity, contamination lapses
The U.S. drug regulator cited Dabur India's Dadra and Nagar Haveli facility for falsified records, a live bird in the raw materials warehouse, and unreliable microbiology testing. The findings raise export-quality concerns for the 140-year-old FMCG major's U.S. health portfolio.
What happened
U.S. FDA flagged Dabur India's Dadra and Nagar Haveli plant for data integrity, contamination and maintenance lapses, including falsified records, a live bird
Key facts
- 140 years
- 30 feet
- 25%
Why this matters
Pre-empt buyer and partner due-diligence questions on quality systems across all plants, since this finding will surface in every U.S. distribution renewal and M&A conversation for the next 12-18 months.